<DOC>
	<DOCNO>NCT00402168</DOCNO>
	<brief_summary>The purpose study learn conversion belatacept cyclosporine tacrolimus preserve kidney function people kidney transplant . The safety tolerability treatment also study</brief_summary>
	<brief_title>A Study BMS-224818 ( Belatacept ) Patients Who Have Undergone Kidney Transplant Are Currently Stable Cyclosporine Tacrolimus Regimen With Without Corticosteroids</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Key Men woman age 18 old 636 month kidney transplant receive cyclosporine tacrolimus calculate GFR ≥35 ≤75mL/min/1.73 m² subject must complete 1 year IM103010ST remain study treatment ( Long Term Extension ) Key Significant infection acute rejection within 3 month prior graft loss due rejection pregnancy positive crossmatch</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>